Fundamental Analysis of VOLITIONRX LTD(NYSEARCA:VNRX) stock

Fundamental Rating

Overall VNRX gets a fundamental rating of 2 out of 10. We evaluated VNRX against 187 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of VNRX have multiple concerns. VNRX is valued quite expensive, but it does show an excellent growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year VNRX has reported negative net income.

In the past year VNRX has reported a negative cash flow from operations.

VNRX had negative earnings in each of the past 5 years.

VNRX had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -248.10%, VNRX is doing worse than 95.19% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-248.1%
ROE	N/A
ROIC	N/A

ROA(3y)-129.77%

ROA(5y)-108.55%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for VNRX so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

VNRX does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, VNRX has more shares outstanding

VNRX has more shares outstanding than it did 5 years ago.

VNRX has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -32.74, we must say that VNRX is in the distress zone and has some risk of bankruptcy.

VNRX's Altman-Z score of -32.74 is on the low side compared to the rest of the industry. VNRX is outperformed by 91.44% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-32.74

ROIC/WACCN/A

WACC8.02%

2.3 Liquidity

VNRX has a Current Ratio of 0.24. This is a bad value and indicates that VNRX is not financially healthy enough and could expect problems in meeting its short term obligations.

Looking at the Current ratio, with a value of 0.24, VNRX is doing worse than 96.26% of the companies in the same industry.

A Quick Ratio of 0.24 indicates that VNRX may have some problems paying its short term obligations.

VNRX's Quick ratio of 0.24 is on the low side compared to the rest of the industry. VNRX is outperformed by 96.26% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.24
Quick Ratio	0.24

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 28.57% over the past year.

Looking at the last year, VNRX shows a very strong growth in Revenue. The Revenue has grown by 88.71%.

Measured over the past years, VNRX shows a very strong growth in Revenue. The Revenue has been growing by 326.41% on average per year.

EPS 1Y (TTM)28.57%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%42.86%

Revenue 1Y (TTM)88.71%

Revenue growth 3Y326.41%

Revenue growth 5YN/A

Sales Q2Q%83.24%

3.2 Future

Based on estimates for the next years, VNRX will show a very strong growth in Earnings Per Share. The EPS will grow by 22.54% on average per year.

Based on estimates for the next years, VNRX will show a very strong growth in Revenue. The Revenue will grow by 142.43% on average per year.

EPS Next Y31%

EPS Next 2Y23.29%

EPS Next 3Y22.54%

EPS Next 5YN/A

Revenue Next Year127.99%

Revenue Next 2Y261.49%

Revenue Next 3Y241.05%

Revenue Next 5Y142.43%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VNRX. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VNRX. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as VNRX's earnings are expected to grow with 22.54% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y23.29%

EPS Next 3Y22.54%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for VNRX!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

VOLITIONRX LTD

NYSEARCA:VNRX (9/18/2024, 8:04:00 PM)

After market: 0.675 +0.06 (+9.9%)

0.6142

-0.04 (-6.23%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap56.57M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-248.1%
ROE	N/A
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.08

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	0.24
Quick Ratio	0.24
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)28.57%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y31%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)88.71%

Revenue growth 3Y326.41%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

VOLITIONRX LTD (VNRX)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens